NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 25, 2025 $30.19 +16.12% $25.85 X 83.21% 0
Aug 21, 2025 $26.96 +4.96% $25.66 X 94.92% 0
Aug 21, 2025 $26.49 +3.10% $25.66 X 96.78% 0
Aug 21, 2025 $41.43 +61.27% $25.66 X 38.54% 0
Gojo200 Gojo200 Amateur
Aug 20, 2025 Bearish $25.69 X 0
Aug 20, 2025 $25.66 +5.33% $25.69 V 99.88% 6
Aug 20, 2025 $25.17 +3.33% $25.69 V 97.98% 1
Aug 20, 2025 $42.09 +0.00% $25.69 V 36.16% 0
Aug 20, 2025 Bullish $25.69 X 1
Aug 18, 2025 $39.22 -2.03% $42.09 X 93.17% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE